Table VII.
Between group analyses by TFAS
HSP patients | X‐SBMA patients | No. voxels | t‐test | |
---|---|---|---|---|
X‐SBMA versus HSP | ||||
CC | 0.33 ± 0.10 | 0.38 ± 0.13 | 16,825 | <0.001 |
CST | 0.42 ± 0.14 | 0.43 ± 0.14 | 4,413 | 0.095 |
HSP patients | PLS patients | No. voxels | t‐test | |
X‐SBMA versus PLS | ||||
CC | 0.32 ± 0.11 | 0.39 ± 0.14 | 12,355 | <0.001 |
CST | 0.39 ± 0.13 | 0.43 ± 0.15 | 4,388 | <0.001 |
PLS patients | X‐SBMA patients | No. voxels | t‐test | |
HSP versus PLS | ||||
CC | 0.36 ± 0.10 | 0.34 ± 0.11 | 9,951 | <0.001 |
CST | 0.43 ± 0.14 | 0.40 ± 0.12 | 4,277 | <0.001 |
Tractwise fractional anisotropy (TFAS) results for between group analyses of the three investigated MNDs. Data are presented as mean values ± SD. A t‐test was performed for the comparison between mean FA values of X‐SBMA and HSP, X‐SBMA and PLS and HSP and PLS, respectively.